期刊文献+

利普司他汀产生菌的菌种选育及培养基优化 被引量:3

Mutation Breeding and Optimization of Fermentation Medium of Lipstatin Producing Strain
原文传递
导出
摘要 以产利普司他汀(lipstatin)的毒三素链霉菌(Streptomyces toxytricini)LIPS-352为出发菌(4 125 mg/L),利用紫外(UV)和亚硝基胍(NTG)诱变,获得一株高产突变株LIPS-N-27-46-42,发酵单位为8 122.9 mg/L。单因素试验结果表明,碳源和氮源对利普司他汀的合成有显著影响,其中葵花籽油较大豆油更适合作为利普司他汀合成的前体和碳源。进一步利用Box-Behnken中心组合设计优化发酵培养基组成,通过响应面分析得到较优培养基配方,使利普司他汀的产量达9 859.8 mg/L,与预测值(10 633.1 mg/L)的相对误差为7.27%。通过菌种选育和配方优化,利普司他汀的效价较出发菌株提高了139.0%。 The Streptomyces toxytricini strain LIPS-352, a producer of lipstatin of 4 125 mg/L, was mutated with UV and nitrosoguanidine. A mutant LIPS-N-27-46-42 was obtained, which yielded 8 122.9 mg/L lipstatin in shake flask cultures. The results of one-factor-at-a-time method showed that carbon sources (glycerol) and nitrogen sources (soybean meal and corn gluten) had a significant effect on the production of lipstatin. Meanwhile, it was found that sunflower oil was better than soybean oil in providing precursor and carbon source for lipstatin synthesis. Then the fermentation medium was further optimized by a Box-Behnken design with response surface methodology. The optimal medium was: glycerol 2.5%, soybean meal 3.35%, corn gluten 1.01%, and sunflower oil 7.56%. The yield of lipstatin was 9 859.8 mg/L, which was 21.4% higher than the original fermentation condition and had a relative error of 7.27% to the predicted value(10 633.1 mg/L). Finally, a 139.0% increase was achieved compared to that of the original strain through mutation breeding and optimization of fermentation medium of lipstatin producing strain.
出处 《中国医药工业杂志》 CAS CSCD 北大核心 2017年第7期1006-1011,共6页 Chinese Journal of Pharmaceuticals
基金 国家"重大新药创制"科技重大专项(2014ZX09201001-005-001)
关键词 毒三素链霉菌 利普司他汀 菌种选育 响应面设计 发酵 Streptomyces toxytricini lipstatin mutation breeding response surface methodology fermentation
  • 相关文献

参考文献2

二级参考文献21

  • 1茆永康,陈代杰,黄为一.表面活性剂PEG600对毒三素链霉菌发酵的影响[J].中国抗生素杂志,2005,30(11):649-652. 被引量:2
  • 2韩俊茹,陈锡永.Lipstatin高产菌株筛选[J].中国抗生素杂志,2007,32(8):459-461. 被引量:5
  • 3沈萍 范秀容 李广武.微生物学实验[M].北京:高等教育出版社,2004..
  • 4Paul H,p.ch H,Ernst K,et al. Leucine derivatives[P]. EP 129 748,1985-01-02.
  • 5Adelbet B,Peter S, Wolfgang W. Process for the production of lip-statin and tetrahydrolipstatin[P]. EP 0 803 576 A2,1997-10-29.
  • 6Varga I.Gondova B,Gajdosikova J.et al. The strain Streptomycestoxytricini lipstatin-producing microorganism and preparation oflipstatin with inscribed strain[P]. WO 2007 078 263 A2,2007-07-12..
  • 7Gasparic A,Svageli N B,Raspor P,et al. Fermentative productionof lipstatin[P]. EP 1 860 194 Al ,2007-11-28.
  • 8Fujs S,Kuscer E,Petkovic H,et al. Process for production of lip-statln and microorganisms there.ore[P]. WO 2010 000 839 Al,2010-01-07.
  • 9胡为民,庄英萍,王永红,储炬,张嗣良.毒三素链霉菌生产利普司他汀的发酵与提取工艺[J].中国医药工业杂志,2007,38(10):705-708. 被引量:11
  • 10颜震,李海军,朱希强,李志民,赵国敏,郭学平,凌沛学.lipstatin发酵工艺的优化[J].食品与药品,2007,9(12A):5-7. 被引量:4

共引文献4

同被引文献14

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部